DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» FRS2
FRS2
Src Activation Plays an Important Key Role in Lymphomagenesis Induced by FGFR1 Fusion Kinases
FGF Signaling Network in the Gastrointestinal Tract (Review)
Integrated Genetic and Epigenetic Analysis Defines Novel Molecular
Flotillins in Receptor Tyrosine Kinase Signaling and Cancer
Frs2 Enhances Fibroblast Growth Factor-Mediated Survival And
Genetic Insights Into the Mechanisms of Fgf Signaling
Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects
Anaplastic Lymphoma Kinase Activates the Small Gtpase Rap1 Via the Rap1-Specific GEF C3G in Both Neuroblastoma and PC12 Cells
The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
FRS2-Dependent SRC Activation Is Required for Fibroblast Growth Factor
FRS2 Is an Oncogene in High Grade Ovarian Cancer
Caenorhabditis Elegans Fibroblast Growth Factor Receptor Signaling Can Occur Independently of the Multi-Substrate Adaptor FRS2
Polyclonal Antibody to CD246 / Anaplastic Lymphoma Kinase Ptyr1507 - Aff - Purified
Foundationone® Current Gene List*
FGF21 Antibody (R30758)
The Hypothesis That Helicobacter Pylori Predisposes to Alzheimer's
JAX SOMASEQ TM Technical Specifications
Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer
Top View
Association of Chromosome 12 Locus with Antihypertensive Response to Hydrochlorothiazide May Involve Differential YEATS4 Expression
1 High Glucose Represses Β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets
Grb2 Monomer&Ndash;Dimer Equilibrium Determines
Sprouty: How Does the Branch Manager Work?
Anti-ALK (Anaplastic Lymphoma Kinase) / CD246 Antibody Mouse Monoclonal Antibody Catalog # AH13245
Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling
A Clinical Entity with a High Frequency of FGFR1 Mutations
Tyrosine Phosphorylation Sites on FRS2 Responsible for Shp2
Development of Covalent Inhibitors That Can Overcome Resistance to First
Structural Systems Biology: Modelling Protein Interactions
New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: a Focus on Novel Driver Kinases
Genequery™ Human Fibroblast Growth Factor Signaling
Crizotinib — Latest Champion in the Cancer Wars? Bengt Hallberg, Ph.D., and Ruth H
Efficient Suppression of FGF-2-Induced ERK Activation by the Cooperative Interaction Among Mammalian Sprouty Isoforms
The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments
Antibody Master List-9-11-17
CBL Mutation-Related Patterns of Phosphorylation and Sensitivity to Tyrosine Kinase Inhibitors
ALK Activation Induces Shc and FRS2 Recruitment: Signaling and Phenotypic Outcomes in PC12 Cells Differentiation
Fibroblast Growth Factor Receptors (Fgfrs) and Noncanonical Partners in Cancer Signaling
Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma
The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer
Preclinical Evaluation of Potential Therapeutic Targets in Dedifferentiated Liposarcoma